Potential combined drug therapy for lung cancer
2021-01-22
(Press-News.org) Most lung cancers are of a type called non-small-cell lung carcinoma (NSCLC). This type of cancer is relatively insensitive to chemotherapy, so NSCLC therapies are usually based on drug treatment. Alectinib is a drug commonly used for treating patients with NSCLC. It addresses a gene rearrangement known as ALK that occurs in 3 to 5% of NSCLC patients (alectinib belongs to a class of drugs called ALK tyrosine kinase inhibitors). It has been unclear, however, whether there is a correlation between the use of alectinib and the poorer prognosis in ALK-NSCLC patients in which secondary cancer mutations are observed -- the latter are known to occur with a frequency of about 25%. Now, Azusa Tanimoto from Kanazawa University and colleagues have investigated this correlation. They found that such secondary mutations reduce the efficacy of alectinib, but they also suggest how to overcome this issue.
The researchers looked at data on 124 NSCLC patients who were treated with ALK tyrosine kinase inhibitors, including alectinib, and who had tested positive for the ALK gene rearrangement. Out of these, for 31 patients, a secondary gene rearrangement known as TP53 mutation was detected. Tanimoto and colleagues looked at whether there is a correlation between alectinib use and TP53 mutations in this group of patients.
The data showed that the cancer's progression-free survival was significantly poorer in patients with TP53 mutations who received alectinib treatment. (The same conclusion was obtained for other treatments with other ALK tyrosine kinase inhibitors.) The resistance to the drugs is linked to the loss of normal p53 function in ALK-rearranged NSCLC; p53 refers to a set of proteins that are known to play a role in preventing cancer formation.
The scientists then investigated how to overcome the adverse effect of alectinib when secondary TP53 mutations occur. Based on their insights into the biochemical mechanisms at play, they proposed to combine alectinib with another drug: ixazomib. The latter is a drug from the class of proteasome inhibitors, which block the action of proteasomes, which in turn break down proteins. Experiments in mice showed promising results: general tumor shrinkage, and complete regression of 3 out of 8 tumors.
The findings of Tanimoto and colleagues show that the combined use of a proteasome inhibitor and alectinib restores the latter's unfavorable efficacy in ALK-rearranged NSCLC. The scientists further conclude: "Based on these [clinical and preclinical] data, this combination therapy is needed to be validated in ... clinical trials."
[Background]
NSCLC
Non-small-cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC) are the two types of lung cancer. 85% of all lung cancers are of the NSCLC type. NSCLCs are less sensitive to chemotherapy than SCLCs, making drug treatment of the highest importance.
Alectinib is a drug used for treating NSCLC, normally with good efficiency. However, in certain scenarios where gene alterations occur, the drug has an adverse effect, as now shown by Azusa Tanimoto from Kanazawa University and colleagues. Tanimoto and colleagues further show that in such situations, combining alectinib with another drug (of the proteasome-inhibitor type) restores its efficacy.
Tyrosine kinase inhibitors
A tyrosine kinase inhibitor is a drug inhibiting (that is, preventing or reducing the activity of) a specific tyrosine kinase. A tyrosine kinase is a protein (enzyme) involved in the activation of other proteins by signaling cascades. The activation happens by the addition of a phosphate group to the protein (phosphorylation); it is this step that a tyrosine kinase inhibitor inhibits. Tyrosine kinase inhibitors are used as anticancer drugs. One such drug is alectinib, used to treat NSCLC.
INFORMATION:
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-22
Metals such as gold or platinum are often used as catalysts. In the catalytic converters of vehicles, for example, platinum nanoparticles convert poisonous carbon monoxide into non-toxic CO2. Because platinum and other catalytically active metals are expensive and rare, the nanoparticles involved have been made smaller and smaller over time.
"Single-atom" catalysts are the logical end point of this downsizing: The metal is no longer present as particles, but as individual atoms that are anchored on the surface of a cheaper support material. Individual atoms can no longer be described using the rules developed from larger pieces of metal, so the rules used to predict which metals will ...
2021-01-22
Normal ageing causes disruptions in the brain that can lead to cognitive decline. Resting-state functional magnetic resonance imaging studies have found significant age-related alterations in functional connectivity across various networks. However, most of the studies have focused primarily on static functional connectivity.
The authors of a recent study published in Cerebral Cortex based their research on the idea that studying the dynamics of resting-state brain activity across the whole-brain functional network can provide a better characterization of age-related changes.
The study was led by Gustavo Deco, director of the Center for Brain and Cognition (CBC) and ICREA research professor at the UPF Department of Information and Communication Technologies (DTIC), and Anira ...
2021-01-22
Chimpanzees, one of the closest relatives of humans, cooperate on a group level - in combative disputes, they even cooperate with group members to whom they are not related. Those involved in fights with neighbouring groups put themselves at risk of serious injury or even death.
Within the context of the Tai Chimpanzee Project researchers observed three chimpanzee communities in Tai National Park in Cote d'Ivoire documenting social relationships, territory range and intergroup encounters amongst others. "We have been able to analyze almost 500 vocal and physical battles from the last 25 years with participation of at least one ...
2021-01-22
Good news for the green transition: Flowery diets help predatory insects help farmers keep pests in check
Predatory insects have been shown to live longer when they have access to nectar and pollen, according to a new study by researchers at the University of Copenhagen. Thus, flowers don't just benefit insects, they help farmers farm sustainably. Predatory insects are skilled pest controllers whose hunting reduces the need for agricultural pesticides.
Until now, it was believed that predatory insects needed prey to survive. But in a systematic review conducted at the University ...
2021-01-22
Researchers in WMG at the University of Warwick, in collaboration with Imperial College London, have found a way to enhance hybrid flow batteries and their commercial use. The new approach can store electricity in these batteries for very long durations for about a fifth the price of current technologies, with minimal location restraints and zero emissions.
The researchers enhanced three hybrid flow cells using nitrogen doped graphene (exposed to nitrogen plasma) in a binder-free electrophoresis technique (EPD).
Wind and solar power are increasingly popular sources for renewable energy. Unfortunately, intermittency issues keep them ...
2021-01-22
GREEN TRANSITION Researchers at the University of Copenhagen have demonstrated that unique fungi strengthen the "immune systems" of wheat and bean plants against aphids. Fungi enter and influence the amount of a plant's own defences, resulting in fewer aphids. The results could serve to reduce agricultural insecticide use and bring Denmark a step further along the path towards its green transition.
Wheat field
Certain fungi are able to establish a close rapport with plants that results in fewer insect infestations and thereby less damage to crops. Until now, it was unclear how these fungi could be used to reduce insect infestations.
"In order for us to really use fungi ...
2021-01-22
PHILADELPHIA, PA (January 22, 2021) - Advancements in diabetes technology have improved quality of life and glycemic control in children with type 1 diabetes. However, data show that a subset of children is being left behind. Those from low-income families and non-Hispanic Black (NHB) children are not experiencing benefits associated with technological advances, and are at higher risk for diabetes complications and adverse outcomes through ongoing poor glycemic control.
In an invited commentary to be published in the journal Diabetes Care, researchers describe how socioeconomic disparities ...
2021-01-22
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer. Using this protein as a target, the team successfully created a CAR T cell therapy - a type of immunotherapy - that killed pancreatic cancer cells in a pre-clinical model.
CAR T cell therapy is an immunotherapy that has shown great promise for the treatment of some blood cancers; however, the treatment of solid tumours using this therapy has proved very difficult. One barrier to success is toxicity in tissues other than the cancer because most of the proteins currently used to target CAR T cells to pancreatic cancer cells and other solid tumours are present in low levels on other normal tissues, ...
2021-01-22
Organic photodetectors (OPDs) have a huge potential for applications in low-cost imaging, health monitoring and near infrared sensing. Yet, before industrially realizing these applications, the performance of these devices still needs to be improved.
Recent research on organic photodetectors based on donor-acceptor systems has resulted in narrow-band, flexible and biocompatible devices, of which the best reach external photovoltaic quantum efficiencies of close to 100%. However, the high noise in the off state produced by these devices limits their specific detectivity, severely reducing the performance, for example ...
2021-01-22
Popular in aquariums all over the world, the zebrafish is native to South Asia. But here in a Cincinnati Children's laboratory, the freshwater variant plays a vital role in scientific discovery.
The iconic stripes are eye-catching but it's the transparency of zebrafish embryonic tissue which are most prized by researchers like Oriana Zinani, a fifth-year doctoral student in molecular developmental biology in the University of Cincinnati College of Medicine. The patterning of the zebrafish's spine gives the appearance of stripes; it is controlled by ...
LAST 30 PRESS RELEASES:
[Press-News.org] Potential combined drug therapy for lung cancer
